Literature DB >> 28254817

Deficient Circumferential Growth Is the Primary Determinant of Aortic Obstruction Attributable to Partial Elastin Deficiency.

Yang Jiao1, Guangxin Li1, Arina Korneva1, Alexander W Caulk1, Lingfeng Qin1, Matthew R Bersi1, Qingle Li1, Wei Li1, Robert P Mecham1, Jay D Humphrey1, George Tellides2.   

Abstract

OBJECTIVE: Williams syndrome is characterized by obstructive aortopathy attributable to heterozygous loss of ELN, the gene encoding elastin. Lesions are thought to result primarily from excessive smooth muscle cell (SMC) proliferation and consequent medial expansion, although an initially smaller caliber and increased stiffness of the aorta may contribute to luminal narrowing. The relative contributions of such abnormalities to the obstructive phenotype had not been defined. APPROACH AND
RESULTS: We quantified determinants of luminal stenosis in thoracic aortas of Eln-/- mice incompletely rescued by human ELN. Moderate obstruction was largely because of deficient circumferential growth, most prominently of ascending segments, despite increased axial growth. Medial thickening was evident in these smaller diameter elastin-deficient aortas, with medial area similar to that of larger diameter control aortas. There was no difference in cross-sectional SMC number between mutant and wild-type genotypes at multiple stages of postnatal development. Decreased elastin content was associated with medial fibrosis and reduced aortic distensibility because of increased structural stiffness but preserved material stiffness. Elastin-deficient SMCs exhibited greater contractile-to-proliferative phenotypic modulation in vitro than in vivo. We confirmed increased medial collagen without evidence of increased medial area or SMC number in a small ascending aorta with thickened media of a Williams syndrome subject.
CONCLUSIONS: Deficient circumferential growth is the predominant mechanism for moderate obstructive aortic disease resulting from partial elastin deficiency. Our findings suggest that diverse aortic manifestations in Williams syndrome result from graded elastin content, and SMC hyperplasia causing medial expansion requires additional elastin loss superimposed on ELN haploinsufficiency.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  aorta; collagen; elastin; smooth muscle cells; vascular remodeling

Mesh:

Substances:

Year:  2017        PMID: 28254817      PMCID: PMC5501334          DOI: 10.1161/ATVBAHA.117.309079

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  32 in total

1.  Vascular wall remodeling in patients with supravalvular aortic stenosis and Williams Beuren syndrome.

Authors:  S M Dridi; A Foucault Bertaud; S Igondjo Tchen; K Senni; A L Ejeil; B Pellat; S Lyonnet; D Bonnet; P Charpiot; G Godeau
Journal:  J Vasc Res       Date:  2005-04-12       Impact factor: 1.934

2.  Supravalvular aortic stenosis. Clinical and pathologic observations in six patients.

Authors:  W N O'Connor; J B Davis; R Geissler; C M Cottrill; J A Noonan; E P Todd
Journal:  Arch Pathol Lab Med       Date:  1985-02       Impact factor: 5.534

3.  Cell biology. Dysfunctional mechanosensing in aneurysms.

Authors:  Jay D Humphrey; Dianna M Milewicz; George Tellides; Martin A Schwartz
Journal:  Science       Date:  2014-05-02       Impact factor: 47.728

4.  Mechanical properties of the common carotid artery in Williams syndrome.

Authors:  Y Aggoun; D Sidi; B I Levy; S Lyonnet; J Kachaner; D Bonnet
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

5.  The middle aortic syndrome: an important feature of Williams' syndrome.

Authors:  D J Radford; P G Pohlner
Journal:  Cardiol Young       Date:  2000-11       Impact factor: 1.093

6.  Rapamycin inhibits smooth muscle cell proliferation and obstructive arteriopathy attributable to elastin deficiency.

Authors:  Wei Li; Qingle Li; Lingfeng Qin; Rahmat Ali; Yibing Qyang; May Tassabehji; Barbara R Pober; William C Sessa; Frank J Giordano; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-14       Impact factor: 8.311

7.  Pathology of coronary arteries, myocardium, and great arteries in supravalvular aortic stenosis. Report of five cases with implications for surgical treatment.

Authors:  J A van Son; W D Edwards; G K Danielson
Journal:  J Thorac Cardiovasc Surg       Date:  1994-07       Impact factor: 5.209

8.  Novel arterial pathology in mice and humans hemizygous for elastin.

Authors:  D Y Li; G Faury; D G Taylor; E C Davis; W A Boyle; R P Mecham; P Stenzel; B Boak; M T Keating
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

9.  Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.

Authors:  Victoria Campuzano; Maria Segura-Puimedon; Verena Terrado; Carolina Sánchez-Rodríguez; Mathilde Coustets; Mauricio Menacho-Márquez; Julián Nevado; Xosé R Bustelo; Uta Francke; Luis A Pérez-Jurado
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

10.  Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis.

Authors:  Ashish Misra; Abdul Q Sheikh; Abhishek Kumar; Jiesi Luo; Jiasheng Zhang; Robert B Hinton; Leslie Smoot; Paige Kaplan; Zsolt Urban; Yibing Qyang; George Tellides; Daniel M Greif
Journal:  J Exp Med       Date:  2016-02-08       Impact factor: 14.307

View more
  20 in total

Review 1.  Elastic fibers and biomechanics of the aorta: Insights from mouse studies.

Authors:  Hiromi Yanagisawa; Jessica Wagenseil
Journal:  Matrix Biol       Date:  2019-03-15       Impact factor: 11.583

2.  What's the Skinny on Elastin Deficiency and Supravalvular Aortic Stenosis?

Authors:  Stoyan N Angelov; Jay Zhu; Jie Hong Hu; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05       Impact factor: 8.311

3.  mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice.

Authors:  Yang Jiao; Guangxin Li; Qingle Li; Rahmat Ali; Lingfeng Qin; Wei Li; Yibing Qyang; Daniel M Greif; Arnar Geirsson; Jay D Humphrey; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-27       Impact factor: 8.311

Review 4.  Vascular Development.

Authors:  Mark W Majesky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03       Impact factor: 8.311

Review 5.  Central artery stiffness and thoracic aortopathy.

Authors:  J D Humphrey; G Tellides
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-09       Impact factor: 4.733

Review 6.  Modeling elastin-associated vasculopathy with patient induced pluripotent stem cells and tissue engineering.

Authors:  Matthew W Ellis; Jiesi Luo; Yibing Qyang
Journal:  Cell Mol Life Sci       Date:  2018-11-20       Impact factor: 9.261

7.  Heterogeneous Cellular Contributions to Elastic Laminae Formation in Arterial Wall Development.

Authors:  Chien-Jung Lin; Marius C Staiculescu; Jie Z Hawes; Austin J Cocciolone; Bridget M Hunkins; Robyn A Roth; Chieh-Yu Lin; Robert P Mecham; Jessica E Wagenseil
Journal:  Circ Res       Date:  2019-10-08       Impact factor: 17.367

Review 8.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

9.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 10.  Elastin, arterial mechanics, and cardiovascular disease.

Authors:  Austin J Cocciolone; Jie Z Hawes; Marius C Staiculescu; Elizabeth O Johnson; Monzur Murshed; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.